
Rapid Development of Type 1 Diabetes Mellitus after Initiation of Anti-PD-1 Therapy
Author(s) -
Muneeb Shah
Publication year - 2016
Publication title -
international journal of cancer and clinical research
Language(s) - English
Resource type - Journals
ISSN - 2378-3419
DOI - 10.23937/2378-3419/3/4/1066
Subject(s) - nivolumab , fulminant , immune system , immune checkpoint , medicine , ipilimumab , immunology , receptor , cancer research , apoptosis , antibody , programmed cell death 1 , pd l1 , type 1 diabetes , immunotherapy , diabetes mellitus , biology , endocrinology , biochemistry